Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. / Perry, Rachel J; Peng, Liang; Barry, Natasha A; Cline, Gary W; Zhang, Dongyan; Cardone, Rebecca L; Petersen, Kitt Falk; Kibbey, Richard G; Goodman, Andrew L; Shulman, Gerald I.
In: Nature, Vol. 534, No. 7606, 09.06.2016, p. 213-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome
AU - Perry, Rachel J
AU - Peng, Liang
AU - Barry, Natasha A
AU - Cline, Gary W
AU - Zhang, Dongyan
AU - Cardone, Rebecca L
AU - Petersen, Kitt Falk
AU - Kibbey, Richard G
AU - Goodman, Andrew L
AU - Shulman, Gerald I.
PY - 2016/6/9
Y1 - 2016/6/9
N2 - Obesity, insulin resistance and the metabolic syndrome are associated with changes to the gut microbiota; however, the mechanism by which modifications to the gut microbiota might lead to these conditions is unknown. Here we show that increased production of acetate by an altered gut microbiota in rodents leads to activation of the parasympathetic nervous system, which, in turn, promotes increased glucose-stimulated insulin secretion, increased ghrelin secretion, hyperphagia, obesity and related sequelae. Together, these findings identify increased acetate production resulting from a nutrient-gut microbiota interaction and subsequent parasympathetic activation as possible therapeutic targets for obesity.
AB - Obesity, insulin resistance and the metabolic syndrome are associated with changes to the gut microbiota; however, the mechanism by which modifications to the gut microbiota might lead to these conditions is unknown. Here we show that increased production of acetate by an altered gut microbiota in rodents leads to activation of the parasympathetic nervous system, which, in turn, promotes increased glucose-stimulated insulin secretion, increased ghrelin secretion, hyperphagia, obesity and related sequelae. Together, these findings identify increased acetate production resulting from a nutrient-gut microbiota interaction and subsequent parasympathetic activation as possible therapeutic targets for obesity.
KW - Acetates
KW - Animals
KW - Brain
KW - Diet, High-Fat
KW - Gastrointestinal Microbiome
KW - Ghrelin
KW - Glucose
KW - Hyperphagia
KW - Insulin
KW - Insulin-Secreting Cells
KW - Metabolic Syndrome X
KW - Obesity
KW - Parasympathetic Nervous System
KW - Rats
KW - Journal Article
KW - Research Support, N.I.H., Extramural
KW - Research Support, Non-U.S. Gov't
U2 - 10.1038/nature18309
DO - 10.1038/nature18309
M3 - Journal article
C2 - 27279214
VL - 534
SP - 213
EP - 217
JO - Nature
JF - Nature
SN - 0028-0836
IS - 7606
ER -
ID: 166693158